18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease

Chem Commun (Camb). 2013 Jan 28;49(8):792-4. doi: 10.1039/c2cc38443d.

Abstract

Three fluoro-barbiturates were synthesised, showing in vivo sedative efficacy. One of them, [(18)F], was synthesised in radiofluorinated form. PET/CT Imaging with [(18)F] identified β-amyloid over-expressing transgenic mice (βA mice) compared to wild type and tau lines. The fluorescent barbiturate 9 was able to label βA plaques in brain sections of βA mice, and co-localise with a fluorescent Zn(II) indicator.

MeSH terms

  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / diagnostic imaging*
  • Alzheimer Disease / genetics
  • Amyloid beta-Peptides / analysis*
  • Amyloid beta-Peptides / genetics
  • Animals
  • Barbiturates* / chemistry
  • Brain / diagnostic imaging*
  • Brain / metabolism
  • Fluorine Radioisotopes* / chemistry
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Plaque, Amyloid / diagnostic imaging*
  • Plaque, Amyloid / genetics
  • Positron-Emission Tomography / methods
  • Up-Regulation
  • tau Proteins / analysis

Substances

  • Amyloid beta-Peptides
  • Barbiturates
  • Fluorine Radioisotopes
  • tau Proteins